Please login to the form below

Not currently logged in
Email:
Password:

Ganymed Pharmaceuticals

This page shows the latest Ganymed Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Astellas agrees €800m deal to buy Belgian biotech Ogeda

Astellas agrees €800m deal to buy Belgian biotech Ogeda

This is the second major deal for Astellas in a few months, following a $1.4bn acquisition of Germany's Ganymed Pharmaceuticals that gave it a gastric cancer antibody (IMAB362) in

Latest news

  • Astellas buys Ganymed to boost immuno-oncology pipeline Astellas buys Ganymed to boost immuno-oncology pipeline

    Astellas has agreed to pay 422m upfront to buy Ganymed Pharmaceuticals, a German biopharma company specialising in antibody-based cancer drugs. ... If all goes according to plan, Ganymed's shareholders could pick up an additional 860m in milestones,

  • Hexal co-founders continue biotech buy up

    The Struengmanns already hold stakes in German biotechnology companies including 4SC and Ganymed Pharmaceuticals, which is developing monoclonal antibody therapeutics to fight solid cancer tumours.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....